Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function
Authors:
- 1 July 1988
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 255 (1) , H153-H159
Abstract
Accumulation of leukocytes and platelets in the injured myocardium may influence coronary arteriolar resistance via release of peptidoleukotrienes and thromboxane A2 (TxA2). Although leukotriene C4 (LTC4) and TxA2 individually reduce coronary blood flow, the effects of their simultaneous administration are not known. Accordingly, the combined effects of intracoronary administration of synthetic LTC4 and thromboxane "mimic" U 46619 on coronary blood flow in patent and severely narrowed coronary arteries and myocardial segmental function were examined in eight anesthetized dogs. Administration of LTC4 and U 46619 (0.3-3 micrograms) showed concentration-dependent reductions in coronary blood flow and myocardial segment shortening. When these eicosanoids (3 micrograms each) were administered in close sequence, coronary blood flow decreased 33% in the patent artery and 47% in the narrowed artery. This reduction in coronary blood flow in the narrowed coronary artery produced a 26% decrease in myocardial segment shortening. Reductions in narrowed coronary artery blood flow and myocardial segment shortening were greater than the sum of changes caused by LTC4 and U 46619 administered separately (P less than 0.05). The histopathology of the narrowed coronary artery revealed endothelial disruption at the site of occlusion and an in vivo thrombus just distal to the site of occlusion. These data suggest marked synergism between the actions of LTC4 and TxA2, which may be released locally at the site of coronary thrombus, on blood flow in a severely narrowed coronary artery, and on segmental function in the region supplied by this vessel.Keywords
This publication has 20 references indexed in Scilit:
- Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs.The Journal of Pharmacology and Experimental Therapeutics, 1984
- Thromboxane release in coronary artery disease: Spontaneous versus pacing-induced anginaAmerican Heart Journal, 1984
- Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.Circulation, 1983
- ROLE OF NEUTROPHILS IN THE DEPOSITION OF PLATELETS DURING ACUTE-INFLAMMATION1983
- Stimulation of leukotriene biosynthesis in human blood leukocytes by platelet-derived 12-hydroperoxy-icosatetraenoic acid.Proceedings of the National Academy of Sciences, 1982
- Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation?Circulation, 1982
- Cardiac anaphylaxis: SRS-A potentiates and extends the effects of released histamineEuropean Journal of Pharmacology, 1980
- Influence of aortic insufficiency on the hemodynamic significance of a coronary artery narrowing.Circulation, 1979
- Platelet aggregation in aortic and coronary venous blood in patients with and without coronary disease. 3. Role of tachycardia stress and propranolol.Circulation, 1978
- Effects of isoproterenol on regional myocardial function, electrogram, and blood flow in conscious dogs with myocardial ischemia.Journal of Clinical Investigation, 1976